Reading EPC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track EPC free→Reading EPC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track EPC free→NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-06-15
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
Recent financial performance is neutral. Earnings quality cannot be assessed as the company is unprofitable. Management's recent track record has been steady. Risk is elevated, and the sector backdrop is a headwind. Compared with sector peers, EPC is below typical. Peer multiples imply a price about 81% below where it trades (it looks expensive on this basis); the read is expensive, growth-justified. Rich on today's multiple, but the three-year horizon reads cheaper once expected earnings growth is included. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 7 valuation methods, at three horizons. Current price $23.00. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $23 EPC trades at 33× p/e — 1.9× the 17× p/e peer median, and above its own 14× history. The market is re-rating it beyond its own range; our $13 fair value is low-confidence here. Analysts: $23–$26. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The market is pricing in roughly 81% near-term growth, well above our forecast of about 6%. This describes what's priced in, not a forecast of the move.
Only expensive valuation — not the full expensive x weak x turbulent stack.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Consumer Staples names rated neutral grew net income 52% of the time over the next year (vs 61% for the rest of the cohort, n=1526).
Over the trailing year it converted -1.51x of net income into operating cash flow.
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, long-term interest rates, real (inflation-adjusted) rates, Fed net liquidity.
3 material management or governance events in the past 24 months, led by executive changes. Historically, Consumer Staples names rated stable grew net income 53% of the time over the next year (vs 47% for the rest of the cohort, n=379).
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $1.05 → $0.63 (-39.7% / 30d). 0 raised, 6 cut, 7 covering analysts.
0 upgrades, 0 downgrades / 30d. 43% of analysts rate Buy.
0 positive, 0 negative / 30d.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$177.
How much price usually moves either way.
On a bad day, this stock has moved -$364.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $4,039.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-15
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: A drop worse than 2% would show ongoing growth problems, especially in North America.
Confirms:Organic net sales decline worse than 2% in Q2 2026 results.
Disproves:Organic net sales show growth or decline less than 2%.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for EPC yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 20, 2026, Edgewell Personal Care Company (the “Company”) determined that Paul R. Hibbert will no longer serve as Chief Supply Chain Officer, effective June 1, 2026. Mr. Hibbert will be eligible to receive payments and benefits provided under the Company’s Executive Severance Plan. The Company wishes to thank Mr. Hibbert for his dedication an…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
$23.00 – $26.00 (median $24.00) · 3 analysts · as of 2026-05-08
Looks more expensive than peers.
Richer than its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
A side-by-side read on sector standing, valuation, and risk versus Household Products.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
EPC Edgewell Personal Care | Below typical Show detailsSector percentile: 25 of 100 | expensive | elevated |
CL Colgate-Palmolive | Typical Show detailsSector percentile: 56 of 100 | full | moderate |
KMB Kimberly-Clark | Above typical Show detailsSector percentile: 91 of 100 | fair | moderate |
CHD Church & Dwight | Typical Show detailsSector percentile: 38 of 100 | expensive | low |
CLX Clorox | Above typical Show detailsSector percentile: 73 of 100 | fair | moderate |
Not investment advice. As of 2026-06-15.
via XLP
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-15.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Continue efforts to enhance gross profit margins through operational efficiencies.
Commitment to maintaining regular dividend payments to shareholders.
Focus on improving cash flow from operations through better working capital management.
Why it matters: Stable dividends show confidence in cash flow. This builds trust with investors.
Confirms:Dividend per share stays at $0.15 in Q3.
Disproves:Dividend per share is cut below $0.15 in Q3.
Why it matters: Sales growth means demand is coming back. It also shows better execution.
Confirms:Organic net sales growth in Q3 exceeds 0%, indicating a return to growth.
Disproves:Organic sales fell again in Q3. This confirms there are still demand problems.
Why it matters: A drop below $1.70 could show bigger problems with profits and costs.
Confirms:Adjusted EPS reported below $1.70 in Q2 2026.
Disproves:Adjusted EPS reported at or above $1.70.
Why it matters: This report will share important updates on sales and profits. It will also cover overall performance.
Confirms one read:The earnings report shows better sales and profits compared to earlier quarters.
Confirms the other:The earnings report shows ongoing drops in sales and profits.
Why it matters: Changes in leadership can affect how well a company runs. This can change profits.
Confirms one read:New supply chain officer announced with a strong track record.
Confirms the other:No new supply chain officer appointed or a weak candidate is named.
Why it matters: Better cash flow shows stronger efficiency and better financial health.
Confirms:Cash flow from operations is positive in Q3. This shows improved efficiency.
Disproves:Cash flow from operations is still negative. This signals ongoing challenges.
Why it matters: Improving cash flow is crucial for funding operations and maintaining dividends. It shows financial health.
Confirms:Cash flow from operations increases by more than 10% compared to the previous quarter.
Disproves:Cash flow from operations decreases or stays flat compared to the previous quarter.
Why it matters: An improvement means better cost control and smarter pricing.
Confirms:Gross profit margin increases by more than 50 basis points in Q2 2026.
Disproves:Gross profit margin decreases or improves by less than 50 basis points.
Why it matters: The Chief Supply Chain Officer left. This could affect operations and costs. Stability in this role is key.
Confirms:A new Chief Supply Chain Officer is appointed quickly and shows strong credentials.
Disproves:The job stays open for a long time. No qualified replacement is found.
of Form 8-K and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information contained in this Current Report on Form 8-K under Item 2.02, including the accompanying Exhibit 99.1, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, exc…
of Form 8-K and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information contained in this Current Report on Form 8-K under Item 2.02, including the accompanying Exhibit 99.1, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, exc…
Completion of Acquisition or Disposition of Assets. On February 2, 2026 (the “Closing Date”), Edgewell Personal Care Company, a Missouri corporation (the “Company”), completed the previously announced sale of its Feminine Care segment (the “Business”), including specified assets and liabilities related to the Business, to Essity Aktiebolag (publ), a listed public limited company incorporated under the Laws of the Kingdom of Sweden (“Buyer”) pursuant to the Asset Purchase Agreement, dated as o…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. At the 2026 Annual Meeting of Shareholders of the Company (the “Annual Meeting”), held on Thursday, February 5, 2026, the Company’s shareholders approved the adoption of the Edgewell Personal Care Company 3 rd Amended and Restated 2018 Stock Incentive Plan (the “3 rd A&R 2018 Plan”), which was adopted by the Board of Directors of the Company on Nov…